| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Dez―01 |
Remdesivir and Renal Outcomes in Hospitalized COVID-19 Patients Without Severe Renal Impairment: A Retrospective Cohort Study |
Xiaotong Li, Kangho Suh, Na He, Iman Karimzadeh, Sandra L. Kane-Gill |
| 2 |
[GO] |
2025―Jul―05 |
Reply: Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19 |
Wesley D. Kufel, Robert W. Seabury, Sarah A. Spinler |
| 3 |
[GO] |
2025―Jul―05 |
Comment: Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19 |
Hinpetch Daungsupawong, Viroj Wiwanitkit |
| 4 |
[GO] |
2025―Apr―24 |
Impact of Remdesivir on Heart Rate and Bradycardia Incidence Among Hospitalized Adults With COVID-19 |
Wesley D. Kufel, Zoey J. Zagoria, Robert W. Seabury, Nabil Zeineddine, Stephen J. Thomas, Sarah A. Spinler, Jeffrey M. Steele |
| 5 |
[GO] |
2024―Sep―09 |
Comment on: Increased Theophylline Plasma Concentrations in a Patient With COVID-19 |
Evelyn Krohmer, Walter E. Haefeli |
| 6 |
[GO] |
2024―Mrz―27 |
Increased Theophylline Plasma Concentrations in a Patient With Covid-19 |
Miriam Rodríguez Fernández, Ana Concepción Sánchez Cerviño, Ana Codonal Demetrio, Nagore Lois Martínez, Benito García Díaz |
| 7 |
[GO] |
2024―Jan―30 |
Monoclonal Antibody Infusions for Outpatient Management of Mild-Moderate COVID-19 |
Hannah B. Knox, Lisa A. Dykes, Lancer A. Scott, Bradley C. Presley, Lara C. Lambert |
| 8 |
[GO] |
2023―Nov―28 |
Efficacy of Fluvoxamine in Outpatients With COVID-19: Understanding Conflicting Conclusions From 2 Recent Meta-Analyses of the Same Clinical Trials |
Marina Sánchez-Rico, Katayoun Rezaei, Eric J. Lenze, Frédéric Limosin, Nicolas Hoertel |
| 9 |
[GO] |
2023―Sep―07 |
Intranasal Theophylline: Potential Treatment for Long COVID Olfactory Dysfunction? |
Olga Hilas, Tina Caliendo |
| 10 |
[GO] |
2023―Jul―31 |
Dosing and Administration Strategies of Tocilizumab in Patients With COVID-19: A Retrospective Cohort Analysis |
Taylor D. Steuber, Thomas Rosandich, Tiffany Cadwallader, Lauren Steil, Madeline Belk, Usha Yendrapalli, Ali Hassoun, Jonathan Edwards |
| 11 |
[GO] |
2023―Mai―05 |
Adverse Events of SARS-CoV-2 Therapy: A Pharmacovigilance Study of the FAERS Database |
Viraaj Pannu, Ndausung Udongwo, Steven Imburgio, Anmol Johal, Anton Mararenko, Helen Pozdniakova, Tasnuva Amin, Swapnil Patel, Mohammad Hossain, Arman Mushtaq, Edward Liu, Jose M. Fune, Joseph Heaton |
| 12 |
[GO] |
2023―Apr―06 |
Comparison of COVID-19 Vaccination and Infection Rates in Adult Patients With Autoimmune Inflammatory Disease on b/tsDMARD Therapy |
Viktoriya Avlasevich, Katharine McCarthy |
| 13 |
[GO] |
2023―Apr―01 |
Efficacy and Safety of Fluvoxamine as Outpatient Treatment for Patients With Covid-19: A Systematic Review and Meta-analysis of Clinical Trials |
Akhil Deepak Vatvani, Andree Kurniawan, Timotius Ivan Hariyanto |
| 14 |
[GO] |
2023―Apr―01 |
Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19 |
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan |
| 15 |
[GO] |
2023―Feb―27 |
A Review of the Data Supporting Use of COVID-19 Vaccinations in the Pediatric Population |
Jeremy S. Stultz, Lea S. Eiland |
| 16 |
[GO] |
2023―Jan―14 |
Comparison of Sedation and Analgesia Requirements in Patients With SARS-CoV-2 Versus Non-SARS-CoV-2 Acute Respiratory Distress Syndrome on Veno-Venous ECMO |
Mariah I. Sigala, Diane Dreucean, Jesse E. Harris, Kevin R. Donahue, Fariedeh Bostan, Prakruthi Voore, Jose Cuevas, Celia Morton |
| 17 |
[GO] |
2022―Dez―28 |
Reply: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19 |
Temeka Dawn Lewis-Wolfson, Kayla Rena Joyner |
| 18 |
[GO] |
2022―Dez―28 |
Comment: Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19 |
Rujittika, PhD Mungmunpuntipantip, Viroj, MD Wiwanitkit |
| 19 |
[GO] |
2022―Nov―14 |
Proportion of Patients on Warfarin Therapy Who Are Eligible for Conversion to a Direct Oral Anticoagulant in the Setting of COVID-19 |
Rachel Hess, Elizabeth Renner, Erin Mouland, Denise Sutter-Long, Nghi Ha |
| 20 |
[GO] |
2022―Okt―29 |
Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19 |
Nancy Kierstin Reid, Kayla Rena Joyner, Temeka Dawn Lewis-Wolfson |
| 21 |
[GO] |
2022―Okt―29 |
Effect of Antidiabetic Therapy on Clinical Outcomes of COVID-19 Patients With Type 2 Diabetes: A Systematic Review and Meta-Analysis |
Kegang Zhan, Liuqi Weng, Li Qi, Luhan Wang, Hao Lin, Xiaoyu Fang, Hong Jia, Xiangyu Ma |
| 22 |
[GO] |
2022―Okt―08 |
Fatal COVID-19 Pneumonia in a Rheumatoid Arthritis Patient Receiving Long-Term Rituximab Therapy |
Chrong-Reen Wang, Wei-Chieh Lin |
| 23 |
[GO] |
2022―Aug―09 |
Effectiveness and Safety of Enoxaparin Versus Unfractionated Heparin as Thromboprophylaxis in Hospitalized COVID-19 Patients: Real-World Evidence |
Lina H. AlLehaibi, Mukhtar Alomar, Abdulaziz Almulhim, Sarah Al-Makki, Nazar R. Alrwaili, Shahad Al-Bassam, Semat Alsultan, Jenan Al Saeed, Mohammad Alsheef, Ivo Abraham, Ahmad Alamer |
| 24 |
[GO] |
2022―Mai―20 |
The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome |
Alyson Katz, Diana Altshuler, John Papadopoulos, Nancy Amoroso, Ronald Goldenberg, Elizabeth Tarras, Kelsey Krolikowski, Jacklyn Hagedorn, David Fridman, Xian Jie Cindy Chen, Eduardo Iturrate, Shari B. Brosnahan |
| 25 |
[GO] |
2022―Mai―19 |
Successful Desensitization to Remdesivir Hypersensitivity in a Patient Undergoing Treatment for COVID-19 |
Da Woon Sim, Eun Myoung, Son Hoyoung |
| 26 |
[GO] |
2022―Mai―02 |
Two Years of the COVID-19 Pandemic: What Lessons Have We Learned? |
Shannon Inglet |
| 27 |
[GO] |
2022―Feb―18 |
Elevated Tacrolimus Levels at Time of Diagnosis of COVID-19 Compared to Baseline Among Hospitalized Organ Transplant Recipients |
Krista Mecadon, Anna Hardesty, Kendra Vieira, Ralph Rogers, Basma Merhi, Adena J. Osband, George Bayliss, MD, Reginald Gohh, Paul Morrissey, Dimitrios Farmakiotis |
| 28 |
[GO] |
2022―Feb―08 |
COVID-19 Vaccine-Associated Pericarditis |
Giuseppe Famularo, Maria Cristina Macciomei |
| 29 |
[GO] |
2022―Jan―13 |
Evaluation of the Clinical Impact of Thromboprophylaxis in Patients With COVID-19 Following Hospital Discharge |
Lindsay A. Courtney, Toby C. Trujillo, Joseph J. Saseen, Garth Wright, Surabhi Palkimas |
| 30 |
[GO] |
2022―Jan―13 |
Medication Changes and Diagnosis of New Chronic Illnesses in COVID-19 Intensive Care Unit Survivors |
Rima A. Mohammad, Cynthia T. Nguyen, Patrick G. Costello, Janelle O. Poyant, Siu Yan Amy Yeung, Kaitlin Landolf, Andy Kim, Katherine L. Artman, Dakota C. Taylor, Michael T. Kenes, Tuqa Alkhateeb, Joanna L. Stollings |
| 31 |
[GO] |
2022―Jan―13 |
Evaluation of Continuous Inhaled Epoprostenol in the Treatment of Acute Respiratory Distress Syndrome, Including Patients With SARS-CoV-2 Infection |
Hannah L. Niss, Adham Mohamed, Timothy P. Berry, Timothy M. Saettele, Michelle M. Haines, Elizabeth L. Thomas |
| 32 |
[GO] |
2022―Jan―11 |
Finally, an FDA Approval for an Immunization Against COVID-19: Hope on the Horizon |
Jason Powell, Christopher R. Piszczatoski |
| 33 |
[GO] |
2021―Sep―09 |
Comment: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019 |
Ju-Tae Sohn |
| 34 |
[GO] |
2021―Sep―06 |
Reply: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019 |
Corey J. Witenko, Audrey J. Littlefield, Sajjad Abedian, Anjile An, Philip S. Barie, Karen Berger |
| 35 |
[GO] |
2021―Sep―02 |
Hypertriglyceridemia in Critically Ill Patients With SARS-CoV-2 Infection |
Wasim S. El Nekidy, Abdullah Shatnawei, Manal M. Abdelsalam, Mariam Hassan, Ruba Z. Dajani, Nouran Salem, Terrence J. Lee St. John, Nadeem Rahman, Fadi Hamed, Jihad Mallat |
| 36 |
[GO] |
2021―Jul―31 |
Comment: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk |
Brittany D. Bissell, Breanne Mefford, J. Chris Donaldson |
| 37 |
[GO] |
2021―Jul―31 |
Reply: Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk |
Xian Jie Cindy Chen, Diana Altshuler, Peter Spiegler, Shari B. Brosnahan |
| 38 |
[GO] |
2021―Jul―29 |
Evaluation of Bivalirudin as the Primary Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation for SARS-CoV-2-Associated Acute Respiratory Failure |
Brittany D. Bissell, Taylor Gabbard, Erica A. Sheridan, Maher A. Baz, George A. Davis, Ayesha Ather |
| 39 |
[GO] |
2021―Jun―28 |
Low-Dose Tocilizumab With High-Dose Corticosteroids in Patients Hospitalized for COVID-19 Hypoxic Respiratory Failure Improves Mortality Without Increased Infection Risk |
Shari B. Brosnahan, Xian Jie Cindy Chen, Juri Chung, Diana Altshuler, Shahidul Islam, Sarun V. Thomas, Megan D. Winner, Allison A. Greco, Jasmin Divers, Peter Spiegler, Daniel H. Sterman, Sam Parnia |
| 40 |
[GO] |
2021―Jun―23 |
Interventions in an Ambulatory Setting to Prevent Progression to Severe Disease in Patients With COVID-19: A Systematic Review |
Eamon O Murchu, Susan Spillane, Paula Byrne, Michelle O’Neill, Patricia Harrington, Máirín Ryan |
| 41 |
[GO] |
2021―Jun―02 |
Sedation Usage in COVID-19 Acute Respiratory Distress Syndrome: A Multicenter Study |
Natalie Tapaskar, Daniel Colon Hidalgo, Grace Koo, Krupa Shingada, Swathi Rao, Raul Rodriguez, Daniel Alcantar, Diana Espinoza Barrera, Raymond Lee, Naveen Rameshkumar, Mukarram Amine, Shelden Rodrigues, Fanny Giron, Akshata Chaugule, Megan A. Rech |
| 42 |
[GO] |
2021―Mai―14 |
The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019 |
Corey J. Witenko, Audrey J. Littlefield, Sajjad Abedian, Anjile An, Philip S. Barie, Karen Berger |
| 43 |
[GO] |
2021―Apr―22 |
Approach to Sedation and Analgesia in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation |
Diane Dreucean, Jesse E. Harris, Prakruthi Voore, Kevin R. Donahue |
| 44 |
[GO] |
2021―Mrz―04 |
Mechanisms and Potential Roles of Glucose-Lowering Agents in COVID-19: A Review |
Helen D. Berlie, Pramodini B. Kale-Pradhan, Tara Orzechowski, Linda A. Jaber |
| 45 |
[GO] |
2020―Dez―11 |
Hydroxychloroquine-Induced Premature Ventricular Contractions in a Patient With COVID-19 Disease |
Dhouha Sahnoun, Maha Abid, Neila Fathallah, Foued Belazreg, Chaker Ben Salem |
| 46 |
[GO] |
2020―Mai―27 |
CORRIGENDUM to Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 (updated to Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19) |
|
| 47 |
[GO] |
2020―Mai―12 |
Myth Busters: Dietary Supplements and COVID-19 |
Kathleen K. Adams, William L. Baker, Diana M. Sobieraj |
| 48 |
[GO] |
2020―Mai―09 |
Emergency Approval of Chloroquine and Hydroxychloroquine for Treatment of COVID-19 |
Christopher R. Piszczatoski, Jason Powell |
